ETF Managers Group’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
$36.2K Buy
+6,359
New +$36.2K ﹤0.01% 666
2021
Q2
Sell
-2,263
Closed -$168K 706
2021
Q1
$168K Sell
2,263
-13,323
-85% -$989K ﹤0.01% 619
2020
Q4
$1.46M Buy
15,586
+5,367
+53% +$502K 0.03% 215
2020
Q3
$403K Sell
10,219
-6,356
-38% -$251K 0.01% 356
2020
Q2
$541K Buy
+16,575
New +$541K 0.02% 254